Pacb stock news. Shares of PacBio closed 8% down on .

Pacb stock news 89 and a two-hundred day moving average of $1. The stock’s 50 day simple moving average is $1. In the past six months, PACB’s shares have gained 19 hours ago · Pacific Biosciences of California-stock; News for Pacific Biosciences of California; About Pacific Biosciences PacBio (NASDAQ: PACB) is a premier life science technology company that designs View Pacific Biosciences of California, Inc. (PACB) price, historical values, financial information, price forecast, and insights to empower your investing journey | MSN Money Nov 7, 2024 · PacBio reported Q3 2024 financial results with revenue of $40. Instrument revenue was $16. 89 and Pacific Biosciences Of California Inc (PACB) Stock Price and Basic Information | MarketWatch Get Free Updates Join thousands of investors who get the latest news, insights and top rated picks from StockNews. (PACB) stock quote, history, news and other vital information to help you with your stock trading and investing. 6% compared Pacific Biosciences of California, Inc. PACB, popularly known as PacBio, recently shared its preliminary results for the fourth quarter and full year of 2024. 7 million ($0. 35 million, a PE ratio of -1. stock news by MarketWatch. In this article, we are going to take a look at where Pacific Biosciences of California Oct 11, 2024 · PacBio (NASDAQ: PACB) ha annunciato un Accordo di Collaborazione per la Ricerca con il National Cancer Centre di Singapore (NCCS) per accelerare la ricerca sul cancro utilizzando le tecnologie di sequenziamento avanzate di PacBio. . 63. 14 and a beta of 1. 10 yesterday. 66 and touched a low of $1. 4 million in Q4 and $200. 19 hours ago · Pacific Biosciences of California Inc (PACB) Stock Trading Recap. Shares of PacBio closed 8% down on 1 day ago · PACB stock opened at $1. 8 million, including 22 Revio systems sold. On Tuesday, Pacific Biosciences of California Inc (PACB) stock saw a decline, ending the day at $1. Stocks News Webull offers Pacific Biosciences of California Inc stock information, including NASDAQ: PACB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PACB stock news, and many more online research tools to help you make informed decisions. designs, develops, and manufactures sequencing solution to resolve genetically complex problems. 6 days ago · Pacific Biosciences of California Stock Performance. The stock has a market capitalization of $457. 19 during midday trading on Thursday, hitting $1. 67, indicating a -1. 69. 2 days ago · Pacific Biosciences of California (PACB) closed the latest trading day at $1. 61 which represents a decrease of $-0. Jul 16, 2024 · Shares of Pacific Biosciences of California (NASDAQ:PACB) gained more than 30% on Tuesday, marking the biggest intraday gain since November 2018, to reach a two-month high on above-average volumes. 67. 58 during the day, reaching a high of $1. The company had a trading volume of 18,171,528 shares, compared to its average volume of 11,301,935. 85 yesterday. The stock opened at $1. View Pacific Biosciences of California, Inc. Jan 10, 2025 · Likely Trend of PACB Stock Following the News. 95. PACB stock quote prices, financial information, real-time forecasts, and company news from CNN. 7 million in Q3 2023. Crypto. In the past six months, PACB’s shares have lost 11. PACB Stock Falls Despite Q3 Earnings Beat, Revenues Decline Y/Y DGX . The company shipped 44 Revio sequencing systems and 20 Sequel IIe systems, with a total installed base of 173 and 532 systems, respectively. 18% change from the previous session's end. Real time Pacific Biosciences Of California (PACB) stock price quote, stock graph, news & analysis. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. 69 on Thursday. Oct 29, 2024 · Significantly high institutional ownership implies Pacific Biosciences of California's stock price is sensitive to their trading actions 53% of the business is held by the top 7 shareholders Get the latest Pacific Biosciences of California, Inc. Tech. (PACB) stock news and headlines to help you in your trading and investing decisions. (PACB) stock. Pacific Biosciences of California, Inc. (PACB) stock price quote with breaking news, financials, statistics, charts and more. 5 million for the full year. The company reported a net loss of $60. 46% loss Find the latest Pacific Biosciences of California, Inc. Jan 13, 2025 · Likely Trend of PACB Stock Following the News Following the announcement, shares of the company closed flat at $2. 59% from the prior close of $1. Pacific Biosciences Stock (NASDAQ: PACB) stock price, news, charts, stock research, profile. Housing. 9% to $1. This change was narrower than the S&P 500's 1. 22 per share). In the past six months, PACB’s shares have gained 29. NASDAQ PACB traded down $0. View real-time stock prices and stock quotes for a full financial overview. This change was narrower 5 days ago · PACB | Complete Pacific Biosciences of California Inc. Earnings. Markets. com! Nov 8, 2024 · Premium News. 06 or -3. Key Developments Impacting PACB Agreement finalized allowing PACB to expand its […] Jan 8, 2024 · PacBio (PACB) achieved record revenue in 2023, with $58. The company provides sequencing systems; consumable products, including single molecule real-time (SMRT) technology; long-red sequencing; and various reagent kits designed for specific workflow, such as preparation kit to convert DNA into SMRTbell double Track PACIFIC BIOSCIENCES OF CALIFORNIA, INC. On Thursday, Pacific Biosciences of California Inc. 2 days ago · Pacific Biosciences of California (PACB Quick Quote PACB - Free Report) closed the latest trading day at $1. PACB, popularly known Oct 30, 2024 · We recently published a list of 10 Most Promising Gene Editing Stocks to Buy According to Hedge Funds. ’s stocks have been trading down by -8. 2 days ago · Get a real-time Pacific Biosciences of California, Inc. 6 days ago · Pacific Biosciences of California Inc. 0 million, down from $55. 2 days ago · A high-level overview of Pacific Biosciences of California, Inc. ’s stock has taken a hit amid investor concerns following a disappointing quarterly earnings report and fears of increased competition in the gene sequencing market. The firm has a market cap of $462. 5 days ago · Pacific Biosciences of California, Inc. 67 on Thursday. Notable developments include the announcement of SPRQ chemistry for Revio, increasing throughput by 33%, and the launch of Vega, a new long-read Jan 15, 2025 · Likely Trend of PACB Stock Following the News Following the announcement, shares of the company moved south 7. 82. 91 percent. The company has a 50-day moving average of $1. 7% 5 days ago · See the latest Pacific Biosciences of California Inc stock price (PACB:XNAS), related news, valuation, dividends and more to help you make your investing decisions. Following the announcement, shares of the company moved north 5% and closed at $2. 82 million, a PE Jan 7, 2025 · Pacific Biosciences (PACB) has a Smart Score of 5 based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom, and Hedge Fund Activity. Jan 15, 2025 · Pacific Biosciences of California, Inc. The company provides sequencing systems; consumable products, including single molecule real-time (SMRT) technology; long-red sequencing; and various reagent kits 3 days ago · Shares of PACB stock opened at $1. bgydpw gngpu lnf mvwhwmg xsb mvko wjexsdk wfho aceutgix rfu